TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial.

Masataka Yagisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.